Fairpoint Group PLC
11 March 2008
Fairpoint Group plc ('the Company')
Re Additional Listing
On 7 March 2008, the Company announced that, as a result of the exercise of
options by employees, application had been made to AIM for the admission of
68,278 ordinary shares of 1p each in the Company to trading.
The Company would like to update the market that, due to the decline in the
Company's share price since the Board meeting to approve the exercise of the
options, there has been a reduction in the number of people exercising their
options at this stage and the number of shares for which application for trading
has been made is 37,661 ordinary shares of 1p each and not 68,278 as previously
announced.
Admission of the 37,661 ordinary shares, which will rank pari passu in all
respects with the existing shares in issue, is expected to occur on 13 March
2008.
Enquiries:
Fairpoint Group plc
Andrew Redmond, Chief Executive Officer 0845 296 0100
Numis Securities
Lee Aston 020 7260 1000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.